« Previous | Contents | Next »
Listen
REFERENCES
Abdulrahim D., Gordon D. and Best D. 2006. Findings of a survey of needle exchanges in England. London: National Treatment Agency.
Bassetti and Battegay. 2004. Staphylococcus aureus infections in injection drug users: risk factors and prevention strategies. Infection. 32:163-169.
Binswanger I.A, Kral AH, Bluthenthal R.N, et al. 2000. High prevalence of abscesses and cellulitis among community-recruited injection drug users in San Francisco. Clin Infect Dis: 30(3):579 - 581.
British Pharmacopoeia. 2004. Volumes I and II. London: BP Commission.
Caflisch C, Wang J, Zbinden R. 1999. The role of syringe filters in harm reduction among injection drug users. Am J Public Health. 89(8):1252
Chignell, A.H. 1992. Endogenous candida endophthalmitis. Journal of Royal Society of Medicine. 85(12):721-4.
Conrad et al. 2000. Development of skin diseases in intravenous drug dependent patients treated with heroin substitution. Schweiz Rundsch Med Prax.89(46):1899-906 [abstract only]
Crofts N., Jolley D., Kaldor J., van Beek I., Wodak A., 1997. Epidemiology of hepatitis C virus infection among injecting drug users in Australia. Journal of Epidemiology and Community Health; 51: 692-697.
Crofts N, Caruana S, Bowden S, Kerger M. 2000. Minimising harm from hepatitis C virus needs better strategies. British Medical Journal. (letter). 321:899.
Darke, S., Ross, J., and Kaye, S. 2001. Physical Injecting Sites Among Injecting Drug Users in Sydney, Australia. Drug and Alcohol Dependenc., 62: 77-82.
Denis B., Dedobbeleer M., Collet T., Petit J., Jamoulle M., Hayani A., et al. 2000. High prevalence of hepatitis C virus infection in Belgian intravenous drug users and potential role of the 'cotton-filter' in transmission: the GEMT Study. Acta Gastroenterol Belg. 63 : 147-153.
Derricott, J., Preston, A., and Hunt, N. 1999. The Safer Injecting Briefing. Liverpool: HIT
DIMS, 2006. Drug Misuse Statistics Scotland 2006. Edinburgh: DIMS
Dix, K. 2002 .CDC's Endorsement of Alcohol Hand Rubs Launches New Era in Hand Hygiene. Infection Control Today.
Fairweather-Tait, S. et al. 1994. Orange juice enhances aluminium absorption from antacid preparation. Eur J Clin Nut, 48(1):71-3.
Florence, A. and Attwood, M. 1998. Physicochemical Principles of Pharmacy. Basingstoke: Palgrave Macmillan.
Fulton. B. and Jeffery, E.H. 1990. Effect of citric and ascorbic acids on aluminium tissue levels in rabbits. Fund am Apple Toxically. 14(4):788-96.
Garden et al. 2003. Evaluation of the provision of single use citric acid sachets to injecting drug users. Effective Interventions Unit: Edinburgh.
Gordon, R.J., and Lowry, F.D. 2005. Bacterial infections in drug users. New England Journal of Medicine, 353: 1945-54.
Griesbach, D., Abdulrahim, D., Gordon, D., and Dowell, K. 2006. Needle exchange provision in Scotland: a report of the national needle exchange survey. Edinburgh: Scottish Executive.
Gruer, L and Ahmed, S. 2001. SCIEH Weekly Report. 35(46).
Hagan H., Thiede H., Weiss N.S., Hopkins S.G., Duchin J.S., Alexander E.R. Sharing of drug preparation equipment as a risk factor for hepatitis C. American Journal of Public Health 2001; 91: 42-46.
Hahn J.A., Page-Shafer K., Lum P.J., Ochoa K., Moss A.R. Hepatitis C virus infection and needle exchange use among young injection drug users in San Francisco. Hepatology 2001; 34 : 180-187.
Haverkos, H., and Lange, R. Serious Infections Other Than Immunodeficiency Virus Among Intravenous Drug Abusers. Journal Of Infectious Diseases, 1990, 161: 894
Health Protection Agency. 2006. Shooting Up: an update. London: HPA.
Hernandes et al. 2004. The Effectiveness of alcohol gel and other hand cleansing agents against important nosocomial pathogens. Brazilian Journal of Microbiology. 35: 33-39.
Huo D and Ouellet LJ. 2007. Needle exchange and injection-related risk behaviors in Chicago: a longitudinal study. J Acquir Immune Defic Syndr. 45(1):108-14.
Hutchinson, S, Taylor, A, Godberg, D and Gruer, L. 2000. Factors associated with injecting risk behaviour among serial community-wide samples of injecting drug users in Glasgow 1990-94: implications for control and prevention of blood-borne viruses. Addiction. 95: 931-40.
Imbert, E., Aznar, C., and Heraud, R. 1999. Citron, Vinaigre, champignons et 'brown sugar': un nouvel enjeu dans la reduction des risque. [Lemon, vinegar, fungi and brown heroin: a new stake in harm reduction]. Unpublished paper: Association Apothicom and Centre de Biologie Medicale Specialisee de l'Institute Pasteur, Paris, France.
Jones, S. et al .2006. Personal communication and raw data viewing of 'Video study of injecting risk behaviours in Bristol'.
Junghans, C. et al. 2005. Recruiting patients to medical research: double blind randomised trial of "opt-in" versus "opt-out" strategies. British Medical Journal. 331:940.
King L.A., 1997. Drug content of powders and other illicit preparations in the UK. Forensic Science International. 85: 135-147.
Koester S, Heimer R, Barón AE, et al. 2003. Re: Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment. (Letter). Am J Epidemiol; 157:376.
Koester S, Glanz J, Barón A. 2005. Drug sharing among heroin networks: implications for HIV and hepatitis B and C prevention. AIDS Behav. 9(1):27-39
Ksobiech K. 2006. Beyond needle sharing: meta-analyses of social context risk behaviors of injection drug users attending needle exchange programs. Subst Use Misuse. 41(10-12):1379-94.
Kuwahara, T, et al. 1998. Effects of pH and osmolality on phlebitic potential of infusion solutions for peripheral parenteral nutrition. J Toxicol Sci. 23(1):77-85.
Levine, D.P. 1991. Skin and Soft Tissue Infections in Intravenous Drug Users. In: Infections in Intravenous Drug Users. Edited by Levine, D.P., and Sobell. J.D. Oxford University Press, New York. pp 183.
Lucidarme D., Bruandet A., Ilef D, Harbonnier, J., Jacob, C., Decoster, A. et al. 2004. Incidence and risk factors of HCV and HIV infections in a cohort of intravenous drug users in the north and east of France. Epidemiology and Infection; 132 : 699-708.
Maliphant, J and Scott, J. 2005. Use of the femoral vein ('groin injecting') by a sample of needle exchange clients in Bristol, UK. Harm Reduction Journal, 2:6.
Mathei C., Shkedy Z., Denis B., Kabali C., Aerts M., Molenberghs G., et al. 2006. Evidence for a substantial role of sharing of injecting paraphernalia other than syringes/needles to the spread of hepatitis C among injecting drug users. Journal of Viral Hepatitis; 13:560-70.
Neale J, Sheard L, Tompkins CN. 2007. Factors that help injecting drug users to access and benefit from services: A qualitative study. Subst Abuse Treat Prev Policy. 30; 2(1):31.
O'Brien R.J and Schroedl B.L. 1991. Talc retinopathy. Optom Vis Sci. 68(1):54-7.
Parry, E, et al. 2004. Statistics from the Scottish Drug Misuse Database 2003/04. Edinburgh: ISD.
[online: http://www.drugmisuse.isdscotland.org/publications/04dmss/pdfs/keypoints.pdf]
Parsons, J. et al. 2002. Over a decade of syringe exchange: results from 1997 UK survey. Addiction. 97(7):845.
Pickering et al. 2003. ' Tracking Homelessness: A Feasibility Study' Edinburgh: Scottish Executive Social Research.
Pittet, D. et al. 2000 . Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Lancet. 365: 1307-12.
Ponton, R. and Scott, J. 2004. Injection preparation processes used by heroin and crack cocaine injectors. Journal of Substance Use. 9(1): 7-19.
Scott et al. 2000. Laboratory study of the effects of citric and ascorbic acids on injections prepared with brown heroin. International Journal of Drug Policy. 11(6): 417-422.
Scott, J. 2000. Development Implementation and Evaluation of Harm Reduction Techniques for Drug Users. PhD Thesis. Aberdeen: The Robert Gordon University.
Scott, J. 2005. Laboratory Study of the Effectiveness of Filters used by Heroin Injectors. Journal of Substance Use. 10:5.
Shekar R, Rice T.W, Zierdt C.H and Kallick C.A. 1985. Outbreak of endocarditis caused by Pseudomonas aeruginosa serotype O11 among pentazocine and tripelennamine abusers in Chicago. Journal of Infectious Diseases. 151(2):203-8.
Spijkerman, I. J., van Ameijden, E. J., Mientjes, G. H., Coutinho, R. A. and van den Hoek, A. 1996. Human immunodeficiency virus infection and other risk factors for skin abscesses and endocarditis among injection drug users. J Clin Epidemiol 49, 1149-1154.
Stein, M.D. 1990. Medical Complications of Intravenous Drug Use. Journal of General Internal Medicine. 5(3): 249.
Stimson, G. 1995. AIDS and injecting drug use in the United Kingdom, 1987-1993: The policy response and the prevention of an epidemic. Social Science and Medicine. 41(5): 699-716.
Stimson, G., Des Jarlais, D., and Ball, A. (Eds) 1998. Drug Injection and HIV Infection. London: UCL Press.
Taylor A., Fleming A., Rutherford J., and Goldberg, D. 2004. Examining the Injecting Practices of Injecting Drug Users in Scotland. Edinburgh: Scottish Executive.
Thiede H, et al, DUIT Study Team. 2007 Prevalence and correlates of indirect sharing practices among young adult injection drug users in five U.S. cities. Drug Alcohol Depend. Suppl 1:S39-47.
Thorpe L.E., Ouellet L.J., Hershow R., Bailey S.L., Williams I.T., Williamson, J. et al . 2002. Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment. American Journal of Epidemiology. 155 : 645-653.
Vlahov, D., Sullivan, M., Astemborski, J and Nelson, K.E. 1992. Bacterial infections and skin cleaning prior to injection among intravenous drug users. Public Health Rep. 107(5):595-8.
Wright N.M, Tompkins C.N. (2006). A review of the evidence for the effectiveness of primary prevention interventions for hepatitis C among injecting drug users. Harm Reduct J.3:27.
« Previous | Contents | Next »